Massachusetts based life sciences companies are at a disadvantage due to difficulties obtaining non-resident distribution licenses.
Virtual pharmaceutical manufacturers in Massachusetts are facing a challenge because of their location. Due to the use of contract manufacturers and third-party logistics providers to distribute products, Massachusetts based pharmaceutical companies are unable to obtain resident state distribution licenses. This in turn may prevent them from obtaining non-resident licenses. Several states require non-resident companies to possess a resident state license in order to obtain a non-resident license. This will make it difficult for Massachusetts to maintain a thriving life sciences industry in their state.
Please click here to read the full article.